发明名称 2' FLUORONUCLEOSIDES
摘要 2′-Fluoro-nucleoside compounds are disclosed which are useful in the treatment of hepatitis B infection, hepatitis C infection, HIV and abnormal cellular proliferation, including tumors and cancer. The compounds have the general formulae:;;wherein Base is a purine or pyrimidine base;R1 is OH, H, OR3, N3, CN, halogen, CF3, lower alkyl, amino, loweralkylamino, di(lower)alkylamino, or alkoxy;R2 is H, phosphate, or a stabilized phosphate prodrug; acyl, or other pharmaceutically acceptable leaving benzyl, a lipid, an amino acid, peptide, or cholesterol; andR3 is acyl, alkyl, phosphate, or other pharmaceutically acceptable leaving group; or a pharmaceutically acceptable salt thereof.
申请公布号 US2016158266(A1) 申请公布日期 2016.06.09
申请号 US201514934655 申请日期 2015.11.06
申请人 Emory University ;UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. 发明人 Schinazi Raymond F.;Liotta Dennis C.;Chu Chung K.;McAtee J. Jeffrey;Shi Junxing;Choi Yongseok;Lee Kyeong;Hong Joon H.
分类号 A61K31/7076;A61K31/7072;A61K31/708;A61K31/7068 主分类号 A61K31/7076
代理机构 代理人
主权项 1. A method of reducing HCV polymerase activity in a host infected with HCV is inhibited comprising administering to the host a β-D-2′-fluoronucleoside wherein the 2′-fluoro of the β-D-2′-fluoronucleoside is alpha (α), or a pharmaceutically acceptable salt or prodrug thereof, optionally in a pharmaceutically acceptable carrier or diluent.
地址 Atlanta GA US